Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
抗 CSF-1R emactuzumab 与抗 PD-L1 atezolizumab 联合用于既往未接受过或已接受过免疫检查点阻断治疗的晚期实体瘤患者
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-004076
Gomez-Roca, Carlos; Cassier, Philippe; Zamarin, Dmitriy; Machiels, Jean-Pascal; Perez Gracia, Jose Luis; Stephen Hodi, F; Taus, Alvaro; Martinez Garcia, Maria; Boni, Valentina; Eder, Joseph P; Hafez, Navid; Sullivan, Ryan; Mcdermott, David; Champiat, Stephane; Aspeslagh, Sandrine; Terret, Catherine; Jegg, Anna-Maria; Jacob, Wolfgang; Cannarile, Michael A; Ries, Carola; Korski, Konstanty; Michielin, Francesca; Christen, Randolph; Babitzki, Galina; Watson, Carl; Meneses-Lorente, Georgina; Weisser, Martin; Rüttinger, Dominik; Delord, Jean-Pierre; Marabelle, Aurelien